B-intervention	0	13	Betamethasone
O	14	16	in
O	17	27	prevention
O	28	30	of
B-condition	31	44	postoperative
I-condition	45	51	nausea
I-condition	52	55	and
I-condition	56	64	vomiting
O	65	74	following
O	75	81	breast
O	82	89	surgery
O	89	90	.

O	91	93	To
O	94	105	investigate
O	106	113	whether
O	114	127	betamethasone
O	128	137	decreases
O	138	141	the
O	142	151	incidence
O	152	154	of
O	155	168	postoperative
O	169	175	nausea
O	175	176	/
O	176	184	vomiting
O	185	186	(
O	186	190	PONV
O	190	191	)
O	192	195	and
O	196	203	reduces
O	204	217	postoperative
O	218	222	pain
O	223	232	following
O	233	240	partial
O	241	251	mastectomy
O	251	252	.

O	253	264	Prospective
O	265	275	randomized
O	275	276	,
O	277	283	double
O	283	284	-
O	284	291	blinded
O	292	297	study
O	297	298	.

O	299	308	Operating
O	309	313	room
O	314	317	and
O	318	332	Postanesthesia
O	333	337	Care
O	338	342	Unit
O	343	345	of
O	346	347	a
O	348	358	university
O	359	367	hospital
O	367	368	.

B-total-participants	369	371	80
B-eligibility	372	375	ASA
I-eligibility	376	384	physical
I-eligibility	385	391	status
I-eligibility	392	393	1
I-eligibility	394	397	and
I-eligibility	398	399	2
I-eligibility	400	405	women
I-eligibility	406	415	scheduled
I-eligibility	416	419	for
I-eligibility	420	428	elective
I-eligibility	429	435	breast
I-eligibility	436	442	cancer
I-eligibility	443	450	surgery
O	450	451	.

O	452	460	Patients
O	461	465	were
O	466	474	randomly
O	475	484	allocated
O	485	487	to
O	488	491	two
O	492	498	groups
O	499	501	in
O	502	508	double
O	508	509	-
O	509	516	blinded
O	517	524	fashion
O	524	525	:
O	526	531	Group
O	532	533	B
O	534	535	(
O	535	548	betamethasone
O	548	549	;
B-intervention-participants	550	552	37
O	553	556	pts
O	556	557	)
O	558	561	and
O	562	567	Group
O	568	569	C
O	570	571	(
B-control	571	578	control
O	578	579	;
B-control-participants	580	582	38
O	583	586	pts
O	586	587	)
O	587	588	.

O	589	594	Group
O	595	596	B
O	597	605	received
O	606	607	8
O	608	610	mg
O	611	613	of
O	614	627	betamethasone
O	628	641	intravenously
O	642	648	before
O	649	652	the
O	653	658	start
O	659	661	of
O	662	669	surgery
O	669	670	.

O	671	674	The
O	675	679	rate
O	680	682	of
O	683	687	PONV
O	688	691	and
O	692	696	pain
O	697	701	were
O	702	710	recorded
O	711	716	using
O	717	718	a
O	719	726	numeric
O	727	733	rating
O	734	739	scale
O	740	741	(
O	741	744	NRS
O	744	745	;
O	746	747	0
O	747	748	-
O	748	750	10
O	750	751	)
O	751	752	,
O	753	755	as
O	756	760	well
O	761	763	as
O	764	770	rescue
O	771	776	doses
O	777	779	of
O	780	791	antiemetics
O	792	793	(
O	793	804	ondansetron
O	804	805	)
O	806	809	and
O	810	820	analgesics
O	821	822	(
O	822	834	ketobemidone
O	834	835	)
O	835	836	.

O	837	842	There
O	843	846	was
O	847	848	a
O	849	860	significant
O	861	866	lower
B-outcome	867	876	incidence
I-outcome	877	879	of
I-outcome	880	893	postoperative
I-outcome	894	900	nausea
I-outcome	901	902	(
I-outcome	902	905	PON
I-outcome	905	906	)
O	907	914	scoring
O	915	918	NRS
O	919	920	â‰¥
O	921	922	1
O	923	925	in
O	926	931	Group
O	932	933	B
O	934	936	in
O	937	940	the
O	941	942	4
O	943	945	to
O	946	948	12
O	948	949	-
O	949	953	hour
O	954	960	period
O	961	969	compared
O	970	974	with
O	975	980	Group
O	981	982	C
O	983	984	(
O	984	985	P
O	986	987	=
O	988	989	0
O	989	990	.
O	990	992	02
O	992	993	)
O	993	994	.

O	995	998	The
B-outcome	999	1009	cumulative
I-outcome	1010	1019	incidence
I-outcome	1020	1022	of
I-outcome	1023	1026	PON
O	1027	1030	was
B-iv-bin-percent	1031	1033	57
I-iv-bin-percent	1033	1034	%
O	1035	1037	in
O	1038	1043	Group
O	1044	1045	B
O	1046	1052	versus
B-cv-bin-percent	1053	1055	68
I-cv-bin-percent	1055	1056	%
O	1057	1059	in
O	1060	1065	Group
O	1066	1067	C
O	1068	1069	(
O	1069	1070	P
O	1071	1072	=
O	1073	1074	0
O	1074	1075	.
O	1075	1077	27
O	1077	1078	)
O	1078	1079	.

O	1080	1083	The
B-outcome	1084	1091	overall
I-outcome	1092	1101	incidence
I-outcome	1102	1104	of
I-outcome	1105	1118	postoperative
I-outcome	1119	1127	vomiting
O	1128	1129	(
O	1129	1132	POV
O	1132	1133	)
O	1134	1137	was
B-iv-bin-percent	1138	1140	18
I-iv-bin-percent	1140	1141	%
O	1142	1145	and
B-cv-bin-percent	1146	1148	20
I-cv-bin-percent	1148	1149	%
O	1150	1152	in
O	1153	1159	Groups
O	1160	1161	B
O	1162	1165	and
O	1166	1167	C
O	1167	1168	,
O	1169	1181	respectively
O	1181	1182	.

B-outcome	1183	1196	Postoperative
I-outcome	1197	1201	pain
O	1202	1205	was
O	1206	1213	reduced
O	1214	1216	by
O	1217	1219	40
O	1219	1220	%
O	1221	1223	in
O	1224	1229	Group
O	1230	1231	B
O	1232	1234	in
O	1235	1238	the
O	1239	1240	4
O	1241	1243	to
O	1244	1246	12
O	1246	1247	-
O	1247	1251	hour
O	1252	1258	period
O	1258	1259	,
O	1260	1263	but
O	1264	1267	the
O	1268	1272	mean
O	1273	1277	dose
O	1278	1280	of
O	1281	1294	postoperative
O	1295	1301	rescue
O	1302	1311	analgesic
O	1312	1315	did
O	1316	1319	not
O	1320	1326	differ
O	1327	1334	between
O	1335	1338	the
O	1339	1345	groups
O	1345	1346	.

O	1347	1359	Preoperative
O	1360	1373	betamethasone
O	1374	1381	reduces
O	1382	1385	the
O	1386	1394	severity
O	1395	1397	of
O	1398	1402	PONV
O	1403	1406	and
O	1407	1411	pain
O	1412	1414	in
O	1415	1423	patients
O	1424	1434	undergoing
O	1435	1443	elective
O	1444	1450	breast
O	1451	1458	surgery
O	1458	1459	.
